SCHEMBL21688077

SCHEMBL21688077

N#Cc1cccc([Si](c2ccccc2)(c2ccccc2)c2ccccc2)c1-c1ccc(-n2c3ccccc3c3ccccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SMN1; SMN2 Q16637 5/20 0.36
ALDH1A1 P00352 4/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
TSHR P16473 2/20 0.36
MAPT P10636 2/20 0.36
STAT3 P40763 1/20 0.35
IMPDH2 P12268 1/20 0.35
PDE10A Q9Y233 1/20 0.34
HDAC4 P56524 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 2/20 0.33
HIF1A Q16665 1/20 0.33
PDE9A O76083 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21688016 0.92 KDM4E (0.34) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL21687973 0.88 KDM4E (0.39) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL21688082 0.88 KDM4E (0.42) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL21687665 0.88 RARG (0.33) SMN1; SMN2ALDH1A1KMT2AMEN1LMNA
SCHEMBL21687767 0.87 SMN1; SMN2 (0.34) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL21687763 0.86 SMN1; SMN2 (0.35) KDM4ESMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL21688242 0.86 KDM4E (0.39) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL21687849 0.86 KDM4E (0.39) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL21687779 0.85 ALDH1A1 (0.33) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL17955105 0.84 KDM4E (0.48) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 KDM4E 2977/4885ATM 1151/4885L3MBTL1 1003/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 KDM4E 2977/4885ATM 1151/4885L3MBTL1 1003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.